The largest database of trusted experimental protocols

Recombinant human vascular endothelial growth factor

Manufactured by R&D Systems
Sourced in United States

Recombinant human vascular endothelial growth factor (VEGF) is a protein produced using recombinant DNA technology. VEGF is a key regulator of angiogenesis, the process of new blood vessel formation from existing vessels.

Automatically generated - may contain errors

2 protocols using recombinant human vascular endothelial growth factor

1

Oligosaccharides Modulate VEGFR-2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oligosaccharides of human milk, such as lactose, lacto N-biose, N-acetyllactosamine, 3′-sialyllactosamine, 6′-sialyllactosamine, 3′-sialyllactose (3SL), and 6′-sialyllactose (6SL), were purchased from Carbosynth Ltd. (Berkshire, UK). Recombinant human vascular endothelial growth factor (VEGF) was supplied by R&D systems Inc. (Minneapolis, MN, USA). Antibodies against the phosphorylated form or total form of VEGF receptor-2 (VEGFR-2), extracellular signal-regulated kinase (ERK), Akt, and p38 were purchased from Cell Signaling Technology (Danvers, MA, USA). The antibody against von Willebrand Factor (vWF) was purchased from Dako (CA, USA). Antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and hoseradish peroxide (HRP)-conjugated secondary antibodies were supplied by Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand
2

Angiogenic Potential Assay on Matrigel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 24-well Matrigel-coated plates and were treated with samples as is described below. The capillary-like tubular formations were considered for evaluating angiogenic or antiangiogenic effects of the test sample of endothelial cells on Matrigel base (Invitrogen, USA) as described before [my article]. Matrigel thawed on ice was added 100 μl/well of a 24 well plate, carefully and incubated for 30 min in 37°C allowing matrigel to form a jelly base with a flat surface. About 40 μl of HUVECs suspension (105 cells/well) were seeded in each well. The wells were treated with 40 μl of test samples with the final concentrations of 5, 50, and 500 μg/ml per well at the same time. Blank or 10 ng/ml recombinant human vascular endothelial growth factor (VEGF) (R and D Systems, USA) alone served as a negative or positive control and culture medium added up to 300 μl. The plate was incubated for 24 h in 37°C and after incubation in vitro endothelial tube formation data were expressed as a percentage of the number of capillary-like tubes in treating wells to untreated control wells of triplicate readings.[4 8 (link)] Capillary-like tube formation was discovered with a Nikon inverted microscope and the images recorded digitally using Angioquant analysis software (Tampere University of Technology, Tampere, Finland).[9 (link)]
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!